Cetera Investment Advisers
XLRN

Cetera Investment Advisers’s Acceleron Pharma XLRN Stock Holding History

Cetera Investment Advisers’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,012
Closed -$346K – 1949
2021
Q3 		$346K Sell
2,012
-6
-0.3% -$785 0.01% 1347
2021
Q2 		$253K Buy
+2,018
New +$255K ﹤0.01% 1526

Cetera Investment Advisers's XLRN Position: Q4 2021 in Review

Cetera Investment Advisers sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,012 shares — an estimated $346K sold.

Cetera Investment Advisers first reported a position in XLRN in Q2 2021 and held it in 2 quarters. The position peaked at $346K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Cetera Investment Advisers reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Cetera Investment Advisers sold 2,012 Acceleron Pharma shares in Q4 2021, an estimated $346K.
  • Cetera Investment Advisers first reported a position in Acceleron Pharma in Q2 2021 and held it in 2 quarters.
  • Cetera Investment Advisers's Acceleron Pharma position peaked at $346K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Cetera Investment Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.